Investors liked what they heard in the company's Q4 update.
News & Analysis: Ampio Pharmaceuticals
AMPE earnings call for the period ending December 31, 2020.
Investors weren't comfortable with FDA feedback on the company's late-stage clinical trial.
The company's lead drug candidate just received some bad news from the FDA.
What goes up must come down.
An important industry analyst has little hope for the tiny company.
The small-cap biopharma stock has exploded at the end of 2017.
These five stocks posted double-digit percentage gains.
February's over -- and investors of these horrendous health-care stocks of the week just might be saying "good riddance." Here's why.
Alexion Pharmaceuticals, Salix Pharmaceuticals, and Ampio Pharmaceuticals could all make health-care headlines this morning.